HORSHAM, Pa.--(BUSINESS WIRE)--Feb 16, 2012-- Quality Systems, Inc.

(NASDAQ: QSII) announced today its dental unit, QSIDental, has entered into a reseller agreement with Suni Medical Imaging, Inc., a pioneer in the manufacture of digital radiography products for dental professionals.

Under the agreement, dental practices, academic institutions, Federally Qualified Health Centers (FQHCs) and community medical and dental healthcare facilities throughout the country can seamlessly integrate Suni's sensors, panoramic, cephalometic and 3-D imaging products with all QSIDental's solutions, including the NextGen(R) Electronic Dental Record (EDR).

The Suni3D family of products provides technologically advanced imaging systems. Suni Digital Panoramic and One-Shot Cephalometric Systems use state-of-the-art technology to provide superior image quality and extensive diagnostic capabilities to help facilitate fast and accurate diagnoses. Suni3D enables practitioners to quickly and easily diagnose anomalies that they normally would not see with traditional 2D imaging systems.

A significant increase in implant, oral and cosmetic surgeries as well as other dental procedures has created the need for more expanded diagnostic capabilities. However, historically, 3-D imaging and other solutions were expensive while entry-level solutions often required significant upgrades. These situations forced many organizations to refer patients to imaging centers, resulting in both an inconvenience to patients and lost revenue.The new agreement with Suni will enable both QSIDental and NextGen EDR client users to meet these evolving diagnostic needs more affordably from a single vendor for all of their digital imaging needs.

"Dentists today are faced with myriad challenges. Our goal is to provide them with the I.T. tools needed to advance patient care and ensure complete collaboration among providers," said Donn Neufeld, executive vice president, EDI and dental at Quality Systems.

"Combining best-in-class 3-D imaging solutions, along with our proven, comprehensive clinical capabilities, creates a product offering that can positively affect patient care." For more than 35 years, QSI has provided dental technology solutions for the dental market that increase productivity, reduce risk, minimize costs and improve patient care. Available clinical product features include: touch screen, voice-activated periodontal software, customized smart notes, built-in smart logic, integrated digital radiography and support for specialties.

"Studies have shown that 3-D technology will represent the fastest-growing segment of the dental market over the next five years," said Paul Tucker, president and CEO of Suni Medical Imaging.

"Our solutions are highly scalable, and this agreement will allow more dental organizations to cost effectively capitalize on this growing trend and better position themselves to meet evolving and future needs." About Suni Medical Imaging, Inc.

At its ISO 13485-2003-certified facility in San Jose, California, Suni designs, manufactures and markets its state-of-the-art sensors and imaging systems for oral health practitioners globally. Suni takes great pride in the performance, reliability, and ease of use of our products and ensure that those standards are met by inventing, refining, and manufacturing our products ourselves in Silicon Valley.

For more Information

About Quality Systems, Inc.

Irvine, Calif.-basedQuality Systems, Inc. and its NextGen Healthcare Information Systems, Inc. subsidiary develop and market computer-based practice management, electronic health records and revenue cycle management applications as well as connectivity products and services for medical and dental group practices and small hospitals. Visit and for additional information.

SAFE HARBOR PROVISIONS FOR FORWARD-LOOKING STATEMENTS This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof.

Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; impact of incentive payments under The American Recovery and Reinvestment Act on sales and the ability of the Company to meet continued certification requirements; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in the Company's periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

NextGen and NextPen are either registered trademarks or trademarks of NextGen Healthcare Information Systems, Inc, in the United States and/or other countries. All other names and marks are property of their respective owners.

CONTACT: Quality Systems, Inc.

Susan J. Lewis, 303-804-0494 or Suni Medical Systems, Inc.


Copyright Business Wire 2012 PUB: 02/16/2012 05:00 AM/DISC: 02/16/2012 05:00 AM